English
  • Notice: Undefined variable: sectorLink in Drupal\five_paisa\Controller\StockDetailController->getSectorLink() (line 450 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Notice: Undefined index: open_price in Drupal\five_paisa\StockService::openPrevData() (line 3918 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: prev_close in Drupal\five_paisa\StockService::openPrevData() (line 3919 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: vol in Drupal\five_paisa\StockService::openPrevData() (line 3923 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_low in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3901 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_high in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3902 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_low in Drupal\five_paisa\StockService::dayLowData() (line 3884 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_high in Drupal\five_paisa\StockService::dayLowData() (line 3885 of modules/custom/five_paisa/src/StockService.php).
  1. Home
  2. Stocks
  3. Genpharma Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Genpharmasec

    Small Cap
    ₹2.06
    +0.04 (1.98%)
    29 June, 2024 03:38 BSE: 531592 NSE: GENPHARMAISIN: INE861N01036

    Start SIP in Genpharmasec

    Start SIP

    Genpharmasec Performance

    Day Range

    • Low 0
    • High 0
    ₹ 2

    52 Week Range

    • Low 0
    • High 0
    ₹ 2
    • Open Price0
    • Previous Close0
    • Volume

    Genpharmasec Share Price

    • Over 1 Month -5.94%
    • Over 3 Month -3.29%
    • Over 6 Month -23.42%
    • Over 1 Year +5.1%

    Genpharmasec Key Statistics

    Genpharmasec Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 106866
    Operating Expenses Qtr Cr 106866
    Operating Profit Qtr Cr 00000
    Depreciation Qtr Cr 00000
    Interest Qtr Cr 00000
    Tax Qtr Cr 0000-1
    Net Profit Qtr Cr 00001
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3126
    Operating Expenses Annual Cr 3025
    Operating Profit Annual in Cr 00
    Depreciation Cr 00
    Interest Annual Cr 00
    Tax Annual Cr 0-1
    Net Profit Annual Cr 01
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -3-3
    Cash from Investing Activity Annual Cr -281
    Cash from Financing Annual Activity Cr 483
    Net Cash Flow Annual Cr 0
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 6515
    Fixed Assets Annual Cr 00
    Total Non Current Assets Annual Cr 301
    Total Current Assets Annual Cr 4019
    Total Assets Annual Cr 7020
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 11
    ROE Annual % 07
    ROCE Annual % 12
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 31
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Genpharmasec

    Genpharmasec Technicals

    EMA & SMA

    Current Price
    ₹2.06
    +0.04 (1.98%)
    pointer
    • Bullish Moving Average
    • ___
    • 8
    • Bearish Moving Average
    • ___
    • 8
    • 20 Day
    • ₹2.02
    • 50 Day
    • ₹2.21
    • 100 Day
    • ₹2.53
    • 200 Day
    • ₹2.69
    • 20 Day
    • ₹1.99
    • 50 Day
    • ₹2.11
    • 100 Day
    • ₹2.76
    • 200 Day
    • ₹2.93

    Genpharmasec Resistance and Support

    PIVOT
    ₹2.06
    Resistance
    First Resistance 2.06
    Second Resistance 2.06
    Third Resistance 2.06
    RSI 51.61
    MFI 56.87
    MACD Single Line -0.06
    MACD -0.04
    Support
    First Support 2.06
    Second Support 2.06
    Third Supoort 2.06

    Genpharmasec Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 243,058 24,305,800 100
    Week 769,724 76,972,400 100
    1 Month 904,713 90,471,343 100
    6 Month 1,853,179 165,359,130 89.23

    Genpharmasec Result Highlights

    Genpharmasec Synopsis

    BSE-Medical-Systems/Equip

    Genpharmasec Ltd belongs to the Industry of Dyes & Pigments. Company’s Total Operating Revenue is Rs. 25.52 Cr. and Equity Capital is Rs. 27.69 Cr. for the Year ended 31/03/2023. Generic Pharmasec Ltd. is a Public Limited Listed company incorporated on 16/11/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1992PLC323914 and registration number is 018572.
    Market Cap 112
    Sales 30
    Shares in Float 38.76
    No of funds 1
    Yield
    Book Value 1.73
    U/D Vol ratio 1.2
    LTDebt / Equity 16
    Alpha -0.01
    Beta 1.2

    Genpharmasec Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23
    Promoters 29.98%59.96%59.96%
    Foreign Portfolio Investors
    Individual Investors 56.18%33.81%32.82%
    Others 13.84%6.23%7.22%

    Genpharmasec Management

    Name Designation
    Mr. Ulhas Narayan Deosthale Executive Director
    Mrs. Sneha Sadhwani Non Exe.Non Ind.Director
    Mr. Rajesh Mirchumal Sadhwani Non Exe.Non Ind.Director
    Mr. Siddhesh Shende Independent Director
    Mr. Mayur Bhatt Independent Director
    Mr. Sachin Prakash Aphandkar Independent Director

    Genpharmasec Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Genpharmasec Corporate Action

    Date Purpose Remarks
    2024-06-27 A.G.M.
    2024-05-24 Audited Results
    2024-03-27 Others inter alia, to consider : 1. To consider and take on record the resignation of Mr. Ulhas Deosthale from the post of Whole-Time Director; issue of equity shares of Re. 1/- in the ratio of 1:1 @ premium of Re. 0.75/-.
    2024-03-26 Independent Director Meeting
    2024-02-12 Quarterly Results

    Genpharmasec MF Shareholding

    Name Amount(cr)

    Genpharmasec FAQs

    What is Share Price of Genpharmasec ?

    Genpharmasec share price is ₹2 As on 29 June, 2024 | 03:24

    What is the Market Cap of Genpharmasec ?

    The Market Cap of Genpharmasec is ₹114.1 Cr As on 29 June, 2024 | 03:24

    What is the P/E ratio of Genpharmasec ?

    The P/E ratio of Genpharmasec is 2481.9 As on 29 June, 2024 | 03:24

    What is the PB ratio of Genpharmasec ?

    The PB ratio of Genpharmasec is 1.8 As on 29 June, 2024 | 03:24

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.